TETRACAINE HYDROCHLORI
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Tetracaine Hydrochloride Ophthalmic Solution is a sterile, 0.5% topical anesthetic in a 5 mL bottle intended for producing surface anesthesia of the eye. The product is regulated by the FDA and is available only by prescription. It must be stored at room temperature between 15–30°C (59–86°F) and protected from light; use is prohibited if the solution appears cloudy, discolored, or contains crystals. The total shelf life is 24 months, with a minimum of 21 months of remaining shelf life required upon receipt by the first government activity. Packaging, labeling, and marking must comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129. Each unit is a 5 mL bottle, and units must be sealed in suitable containers to prevent damage or breakage, packed in commercial shipping containers, and shipped by the fastest traceable means—parcel post is prohibited. The item is governed by the DLA Master List of Technical and Quality Requirements, which take precedence over other standards like ASTM D3951. Hazardous material packaging requirements apply if classified under Fed-Std-313; otherwise, commercial packaging per ASTM D3951 is acceptable, but DLA requirements override. The contract specifies a quantity of 2 bottles with delivery required within 5 days to Fort Stewart, Georgia. The product code is NDC 82260-0920-05 under Bausch & Lomb Incorporated and NDC 68682-0920-05 under AmerisourceBergen Drug Corp. All packaging must be labeled and marked in strict accordance with the specified standards and include government-unique identifiers as required.
General Info
Agency
NAICS
Place of Performance
BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
TETRACAINE HYDROCHLORIDE OPHTHALMIC SOLUTION
RX ONLY. UNIT OF ISSUE IS A BOTTLE CONTAINING 5 ML.
0.5% ACTIVE INGREDIENT; HIGH VISCOSITY; STERILE; TOPICAL ANESTHETIC; 5
ML BOTTLE; USED TO PRODUCE SURFACE ANESTHESIA OF THE EYE; STORE AT A
ROOM TEMPERATURE 15-30 DEG C (59-86 DEG F), PROTECT FROM LIGHT, DO NOT
USE IF SOLUTION CONTAINS CRYSTALS, CLOUDY,OR DISCOLORED. KEEP CONTAINER
TIGHTLY CLOSED
TOTAL SHELF LIFE IS 24 MONTHS.. THERE SHALL BE A MINIMUM OF 21 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF RECIPT BY THE FIRST GOVERNMENT
ACTIVITY.. STORE AT A ROOM TEMPERATURE 15-30 DEG C (59-86 DEG F).
LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD
NO. 1A DATED 4 FEBRUARY 2013. 6/25/2015
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
1 BT = 5 ML
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SPE2DP-26-T-4586
SECTION B
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N 987331
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC68682-0920-05
BAUSCH & LOMB INCORPORATED 93180 P/N NDC82260-0920-05
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017796767 0001 BT 2.000
NSN/MATERIAL:6505016414148
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
SPE2DP-26-T-4586
SECTION B
PR: 7017796767 PRLI: 0001 CONT’D
W33RBS
0087 CS BN CO A COMPOSITE
AWCF SSF
BLDG 1509 WEST 6TH STREET
FORT STEWART GA 31314-5185
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W33RBS
0087 CS BN CO A COMPOSITE
AWCF SSF
BLDG 1509 WEST 6TH STREET
FORT STEWART GA 31314-5185
US
MARKFOR
W33RBS
0087 CS BN CO A COMPOSITE
AWCF SSF
BLDG 1509 WEST 6TH STREET
FORT STEWART GA 31314-5185
US
M/F: (TCN) W33RBS62180550
RDD: 232
PROJ: TP 1
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:08/12/2026
SPE2DP-26-T-4586 NSN/Part Number: 6505-01-641-4148 Quantity: 2 BT Purchase Request: 7017796767QTY: 2 Delivery: 5 days ADO
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
